phenylalanine has been researched along with Stroke in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, D; Liu, H; Pu, J; Yang, L; Zhou, Q | 1 |
| Fei, G; Li, Q; Lin, L; Qi, B; Xu, B; Zhang, Y | 1 |
| Kokaia, Z; Lindvall, O; Memanishvili, T; Monni, E; Tatarishivili, J; Tornero, D; Tsiskaridze, A | 1 |
| Cayabyab, FS; Gowribai, K; Walz, W | 1 |
| Califf, RM; Chiang, FT; Giles, TD; Haffner, SM; Holman, RR; Mazzone, T; McMurray, JJ; Preiss, D; Rutten, GE; Standl, E; Sun, JL; Thomas, LE; Tognoni, G | 1 |
| Ormstad, H; Sandvik, L; Verkerk, R | 1 |
| Zhang, W; Zhang, XA | 1 |
| Harumi Higuchi Dos Santos, M; Holman, RR; Lopes, RD; McMurray, JJ; Pieper, K; Sharma, A; Sun, JL | 1 |
| Cao, W; Glushakov, AV; Martynyuk, AE; Mecca, AP; Seubert, CN; Shah, HP; Shi, P; Sumners, C | 1 |
| Hartfield, DS; Yager, JY | 1 |
| Allawi, J; Horrobin, DF; Loder, C | 1 |
| Dennis, DM; Glushakov, AV; Kagiyama, T; Martynyuk, AE; Ozcan, MS; Phillips, MI; Roose, B; Seubert, CN; Sumners, C | 1 |
| Chapman, DF; Lapchak, PA; Zivin, JA | 1 |
| Asahi, K; Asahi, M; del Zoppo, GJ; Fini, ME; Jung, JC; Lo, EH | 1 |
1 review(s) available for phenylalanine and Stroke
| Article | Year |
|---|---|
Neurologic manifestations of iron deficiency in childhood.
Topics: Anemia, Iron-Deficiency; Brain Diseases; Child; Child, Preschool; Developmental Disabilities; Dopamine; gamma-Aminobutyric Acid; Humans; Infant; Iron Deficiencies; Phenylalanine; Pseudotumor Cerebri; Serotonin; Stroke | 2002 |
1 trial(s) available for phenylalanine and Stroke
| Article | Year |
|---|---|
Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems.
Topics: Adrenergic Fibers; Adrenergic Uptake Inhibitors; Antidepressive Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Fatigue Syndrome, Chronic; Humans; Locus Coeruleus; Lofepramine; Methylation; Multiple Sclerosis; Norepinephrine; Pain; Phenylalanine; Severity of Illness Index; Stroke; Stroke Rehabilitation; Tegmentum Mesencephali; Treatment Outcome; Vitamin B 12 | 2002 |
12 other study(ies) available for phenylalanine and Stroke
| Article | Year |
|---|---|
Peripheral blood and urine metabolites and biological functions in post-stroke depression.
Topics: Depression; Humans; Metabolomics; Phenylalanine; RNA, Transfer; Stroke | 2022 |
Metabolomic Characterization of Acute Ischemic Stroke Facilitates Metabolomic Biomarker Discovery.
Topics: Argininosuccinic Acid; Biomarkers; Glucosamine; Glycerophospholipids; Humans; Ischemic Stroke; Lysine; Metabolomics; Oxygen; Phenylalanine; RNA, Transfer; Stroke; Tryptophan; Tyrosine | 2022 |
Poly(ester amide) microspheres are efficient vehicles for long-term intracerebral growth factor delivery and improve functional recovery after stroke.
Topics: Absorbable Implants; Adipates; Amides; Animals; Anti-Inflammatory Agents; Behavior, Animal; Biocompatible Materials; Butylene Glycols; Drug Delivery Systems; Infarction, Middle Cerebral Artery; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Microspheres; Particle Size; Phenylalanine; Polyesters; Polymers; Recombinant Proteins; Stroke; Swine; Vascular Endothelial Growth Factor A | 2020 |
Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity.
Topics: Analysis of Variance; Animals; CD11b Antigen; Disease Models, Animal; Ectodysplasins; Gene Expression Regulation, Enzymologic; Glial Fibrillary Acidic Protein; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microglia; Minocycline; Phenylalanine; Protease Inhibitors; Rats; Rats, Wistar; Stroke; Stroke, Lacunar; Thiophenes; Time Factors | 2013 |
Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Topics: Aged; Antihypertensive Agents; Comorbidity; Controlled Clinical Trials as Topic; Cyclohexanes; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Outcome Assessment, Health Care; Phenylalanine; Predictive Value of Tests; Risk Factors; Stroke; Tetrazoles; Valine; Valsartan | 2013 |
Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Middle Aged; Phenylalanine; Stroke; Tyrosine | 2016 |
A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.
Topics: Aged; Biomarkers; Caproates; Case-Control Studies; Depression; Dicarboxylic Acids; Female; Glyceric Acids; Humans; Hydroxy Acids; Male; Metabolome; Middle Aged; Phenylalanine; Pseudouridine; Stroke; Tyrosine | 2015 |
International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Asia; Australia; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Europe; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Incidence; Latin America; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nateglinide; New Zealand; North America; Outcome Assessment, Health Care; Phenylalanine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; South Africa; Stroke; Valsartan | 2017 |
Efficacy of 3,5-dibromo-L-phenylalanine in rat models of stroke, seizures and sensorimotor gating deficit.
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Endothelin-1; Gait Disorders, Neurologic; Glutamic Acid; Male; Pentylenetetrazole; Phenylalanine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Seizures; Stroke | 2009 |
Neuroprotective action of halogenated derivatives of L-phenylalanine.
Topics: Animals; Disease Models, Animal; In Vitro Techniques; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Stroke; Synaptic Transmission; Tyrosine | 2004 |
Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Fibrinolytic Agents; Humans; Intracranial Embolism; Metalloendopeptidases; Phenylalanine; Protease Inhibitors; Rabbits; Stroke; Thiophenes; Thromboembolism; Tissue Plasminogen Activator | 2000 |
Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Topics: Animals; Brain; Brain Ischemia; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred Strains; Mice, Knockout; Neuroprotective Agents; Phenylalanine; Protease Inhibitors; Stroke; Thiophenes; Transcription, Genetic | 2000 |